Navigation Links
HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,,,Virus DNA

allowing simultaneous detection of HSV and IAC.

Amplification is performed with a PCR mixture that contains the HSV-TC and IAC molecular beacons, HSV PCR primers, dNTPS, Taq2000 DNA polymerase, an IAC DNA template, and an optimized PCR buffer. PCR is performed in a real-time spectrofluorometric thermal cycler. The presence of HSV-1 or HSV-2 DNA is determined by comparing the endpoint fluorescence value and/or the threshold cycle (Ct) values of the HSV DNA to the IAC control. As shown in Figure 2, 105 to 102 copies of HSV-1 (Figure 2) and HSV-2 (Figure 2) are reliably detected with the HSV-TC molecular beacon.

Fig.2

Conclusions

Stratagenes single-tube HSVision molecular beacon detection module offers several advantages over existing HSV screening techniques: The test is performed in a closed tube so no post-PCR manipulation of samples is required. Because the entire reaction takes place in one tube, the test saves time and effort and significantly reduces the risk of PCR product carry-over contamination. Furthermore, this multiplexed assay includes both an HSV-specific molecular beacon as well as an internal control so assay performance and validation are realized. Hence, a true negative result can be discriminated from a false negative result due to PCR failure. In addition, the inclusion of both high- and low-copy number mixed HSV-1/HSV-2 DNA standards permits assay sensitivity to be validated. Using a 96-well format, samples can be completely screened in approximately 4 hours.


REFERENCES
  1. Stanberry, L.R. (1998) Dermatol. Clin. 16(4): 811-816.
  2. Roizman, B. and Sears, A.E. (1996) In Fields Virology V.2, 3rd ed., (Eds. B.N., Knipe, D.M., and P.M Howley) Philadelphia Lippinco
    '"/>


Source:


Page: All 1 2 3 4

Related biology technology :

1. Detect Single Nucleotide Sequence Changes with Mx4000 Molecular Beacon Allelic Discrimination Kits
2. Genotyping Single Nucleotide Polymorphisms with Molecular Beacons
3. New Protocols for Isolating High- Molecular-Weight Genomic DNA
4. Molecular Biology:Easy Dephosphorylation and Rapid DNA Ligation
5. Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A
6. Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A
7. Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers
8. Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36)
9. Near Infrared Technology and Optical Agents For Molecular Imaging
10. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
11. A New PCR-based Mycoplasma Detection Method

Post Your Comments:
(Date:11/5/2009)..., CA, November 5, 2009 S...n using proprietary taste receptor-based technolog...ood, beverage, and ingredient supply industries, t...ncial results for the third quarter ended Septembe...ird quarter of 2009, compared to $4.0 million for ...
(Date:11/5/2009)...exas, Nov. 5 SpineSmith Partners h... to co-develop a unique scaffold that mimics the s...aluation of several commercial products by SpineSm...pany believes the GenOsteo scaffold represents a s...a unique and ideal environment for the delivery of...
(Date:11/5/2009)... Drug safety specialty firm BioSoteria a...Informatics earned the Certified Professional in L...rom the American Society for Training and Developm...ell has more than fifteen years of medical communi... responsible for the development of the company,s ...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro...B) November 5, 2009 -- Professional Reprographics,...cs company is pleased to present Brooke Sanders to...aphics/PR specialist. The addition of Brooke to th...th within Professional Reprographics., , ,Brooke b...
Breaking Biology Technology:SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4
...ay 29 The Gerresheimer,Group today opened a new p...The high-tech production facility constructed in D...ers. Specializing in high-quality pharmaceutical,v...s the pharma & life,science industry on both a...EO of Gerresheimer AG, describes the investment as...
...RNewswire-FirstCall/ - YM BioSciences Inc. (NYSE A... that identifies, develops and commercializes diff...announced that a poster presentation will report r... BIOMAb/TheraCIM/h-R3) in patients with head and n... India), a licensee of CIMAB SA, YM,s licensor, at...
...0th patient was supported with the,Berlin Heart EX...nown as the,"Berlin Heart") since the first implan...onth-old girl, received the device at the Children...ssfully transplanted in the meantime. , Alejan...h left,ventricular non compaction and dilative car...
Other Biology Technology:Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 2Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 3YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 2YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 3500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2
(Date:11/5/2009)...The National Association of Biology Teachers (NABT...f biological sciences at Naugatuck Valley Communit...he 2009 Evolution Education Award during the NABT ...eld 11-14 November 2009 in Denver, Colorado. , T... American Institute of Biological Sciences,(AIBS)...
(Date:11/4/2009)... LEADS: (top news in natural science) , Unit...tates uses less water today than it did 35 years a...ines in water use are partly attributable to alter...ficient irrigation systems. According to the lates...used in the United States goes to cooling thermoel...
(Date:11/4/2009)...The Singapore laboratory that deciphered the DNA c...) and elephant shark, has joined The Genome 10K Pr...ble repository of DNA sequences on 10,000 species ... scale that currently can not be achieved. , Par... a paper published in the Nov. 5, 2009 issue of th...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 53006 1American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 53006 2Thousands of Maine Residents Could Lose Private Insurance Study Shows 53001 1Thousands of Maine Residents Could Lose Private Insurance Study Shows 53001 2Cell Therapeutics Inc Announces Closing of Public Offering of Common Stock and Warrants 52996 1Cell Therapeutics Inc Announces Closing of Public Offering of Common Stock and Warrants 52996 2
...g to the growing popularity of a plant-based sweet...y announced it is developing a new standard to be ...ll help food and beverage manufacturers assure the...omments from the food and beverage industry as wel...new standard for this new sweetener, Rebaudioside ...
...g? , A new study suggests that while health care ...conomy, achieving a substantial, sustainable reduc...he author, who completed health care policy litera...spite far greater expenditures, US hospitalization...ds are all lower than they are in other first-worl...
...atments is the difficulty of aiming these treatmen...ealthy cells in the process. But a new study by Mc... into how scientists might develop therapies and d...ing normal healthy cells , Mick Bhatia, scientifi...search Institute in the Michael G. DeGroote School...
Other Biology News:New standard for popular stevia-based sweetener to assure product's quality 2Plastic and reconstructive surgery -- in brief 2Plastic and reconstructive surgery -- in brief 3Scientists can now differentiate between healthy cells and cancer cells 2
... offers 144 highly successful analytical technique...nd tested protocol contains detailed, step-by-step...ernative procedures, informative explanations and ...ics covered range from protein and peptide electro...
... homogeneous and gradient polyacrylamide gels.Sepa...and isoelectric focusing gels.Save time and improv..., and staining kits.Achieve detection sensitivity ...use silver staining kits. Category: Electrophoresi...
Pig Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
Rhesus Serum from Innovative Research
Biology Products: